Anil Kumar Jaiswal, Dmitriy Minond, Amarjit Mishra. "Targeting ADAM17 to dampen dendritic cell-mediated type 2 immune responses and airway inflammation associated with allergic asthma." Scientific Reports, 2025. doi:10.1038/s41598-025-14569-w